Equity Overview
Price & Market Data
Price: $0.0296
Daily Change: +$0.0031 / 10.48%
Daily Range: $0.0245 - $0.0297
Market Cap: $11,327,580
Daily Volume: 677,840
Performance Metrics
1 Week: 15.85%
1 Month: 76.19%
3 Months: 228.9%
6 Months: 193.1%
1 Year: 124.2%
YTD: 238.3%
Details
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.